• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药学与治疗学委员会COVID-19应对计划

Pharmacy and Therapeutics Committee Preparedness Plan for COVID-19.

作者信息

Abu Esba Laila Carolina, Al-Abdulkarim Hana Abdullah, Alrushidan Ahmed, Al Harbi Mohammed

机构信息

Clinical Pharmacist, Ministry of National Guard, Health Affairs, and Joint Appointment Lecturer of Pharmacy Practice at King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

King Abdullah International Medical Research Centre, Riyadh, Saudi Arabia.

出版信息

Glob J Qual Saf Healthc. 2020 May 19;3(2):55-64. doi: 10.36401/JQSH-20-9. eCollection 2020 May.

DOI:10.36401/JQSH-20-9
PMID:37334146
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10270544/
Abstract

As the Pharmacy and Therapeutics (P&T) committee acts as an advisory committee on therapeutic options, it is important during pandemics, such as the current Coronavirus disease 2019 pandemic, to quickly search the evidence, be able to select the most appropriate therapies despite the limited evidence, and make appropriate decisions related to which drugs to procure and stock. Potential therapies and recommendations to the P&T committee at a large healthcare institution as means of a preparedness plan are reviewed here.

摘要

由于药学与治疗学(P&T)委员会充当治疗方案的咨询委员会,在大流行期间,如当前的2019年冠状病毒病大流行,迅速检索证据、尽管证据有限仍能够选择最合适的治疗方法以及就采购和储备哪些药物做出适当决策非常重要。本文回顾了作为准备计划手段向大型医疗机构的P&T委员会提出的潜在治疗方法和建议。

相似文献

1
Pharmacy and Therapeutics Committee Preparedness Plan for COVID-19.药学与治疗学委员会COVID-19应对计划
Glob J Qual Saf Healthc. 2020 May 19;3(2):55-64. doi: 10.36401/JQSH-20-9. eCollection 2020 May.
2
The Pharmacy and Therapeutics Committee Part 1: overview.药学与治疗学委员会 第1部分:概述
Hosp Formul. 1983 May;18(5):517-8, 523-4, 533 passim.
3
COVID-19 pandemic: Response plan by the Johns Hopkins Aramco Healthcare inpatient pharmacy department.COVID-19 大流行:约翰霍普金斯阿美石油公司医疗保健住院药房部门的应对计划。
Res Social Adm Pharm. 2021 Jan;17(1):2009-2011. doi: 10.1016/j.sapharm.2020.05.016. Epub 2020 May 18.
4
Hospital Pharmacist experience in the Intensive Care Unit: Plan COVID.医院药剂师在重症监护病房的经验:“计划新冠”。
Farm Hosp. 2020 Jun 12;44(7):32-35. doi: 10.7399/fh.11510.
5
Strategies for success in creating an effective multihospital health-system pharmacy and therapeutics committee.创建高效的多医院健康系统药学与治疗学委员会的成功策略。
Am J Health Syst Pharm. 2018 Apr 1;75(7):451-455. doi: 10.2146/ajhp170531.
6
COVID-19 pandemic preparedness: A practical guide from an operational pharmacy perspective.《COVID-19 大流行准备:来自运营药房视角的实用指南》。
Am J Health Syst Pharm. 2020 Sep 18;77(19):1598-1605. doi: 10.1093/ajhp/zxaa212.
7
Provision of clinical pharmacy services during the COVID-19 pandemic: Experiences of pharmacists from 16 European countries.新冠疫情期间临床药学服务的提供:来自16个欧洲国家药剂师的经验
Res Social Adm Pharm. 2021 Aug;17(8):1507-1517. doi: 10.1016/j.sapharm.2020.11.017. Epub 2020 Nov 30.
8
COVID-19 pandemic preparedness: A practical guide from clinical pharmacists' perspective.《COVID-19 大流行防范:临床药师视角的实用指南》
Am J Health Syst Pharm. 2020 Sep 4;77(18):1510-1515. doi: 10.1093/ajhp/zxaa204.
9
Developing COVID-19 vaccine recommendations during the pandemic: The experience of Serbia's Expert Committee on Immunization.在大流行期间制定 COVID-19 疫苗接种建议:塞尔维亚免疫专家委员会的经验。
Front Public Health. 2022 Nov 17;10:1056670. doi: 10.3389/fpubh.2022.1056670. eCollection 2022.
10
Hospital Pharmacy in the multidisciplinary team of COVID inpatient units.新冠住院病房多学科团队中的医院药学
Farm Hosp. 2020 Jun 12;44(7):40-42. doi: 10.7399/fh.11517.

引用本文的文献

1
Lomitapide: A Medication Use Evaluation and a Formulary Perspective.洛美他派:药物使用评估及处方集视角
Glob J Qual Saf Healthc. 2024 May 2;7(2):59-62. doi: 10.36401/JQSH-23-32. eCollection 2024 May.
2
Pharmacoeconomic Trends, Applications, and Potential Developments.药物经济学趋势、应用及潜在发展
Glob J Qual Saf Healthc. 2020 Jun 8;3(2):36-37. doi: 10.36401/JQSH-20-X3. eCollection 2020 May.
3
Can't find the antidote: A root cause analysis.找不到解毒剂:根本原因分析。
Front Pharmacol. 2022 Sep 6;13:895841. doi: 10.3389/fphar.2022.895841. eCollection 2022.
4
Impact of the COVID-19 Pandemic on Cancer Care: A Global Collaborative Study.2019年冠状病毒病大流行对癌症护理的影响:一项全球合作研究。
JCO Glob Oncol. 2020 Sep;6:1428-1438. doi: 10.1200/GO.20.00351.

本文引用的文献

1
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.羟氯喹和阿奇霉素治疗 COVID-19:一项开放标签非随机临床试验的结果。
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
2
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.洛匹那韦-利托那韦治疗成人重症 COVID-19 患者的临床试验。
N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.
3
Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis.新型冠状病毒肺炎的临床、实验室和影像学特征:系统评价和荟萃分析。
Travel Med Infect Dis. 2020 Mar-Apr;34:101623. doi: 10.1016/j.tmaid.2020.101623. Epub 2020 Mar 13.
4
Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study.利巴韦林联合洛匹那韦/利托那韦与洛匹那韦/利托那韦单独治疗 2019 年冠状病毒病:一项回顾性队列研究。
J Infect. 2020 Jul;81(1):e1-e5. doi: 10.1016/j.jinf.2020.03.002. Epub 2020 Mar 11.
5
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).羟氯喹治疗严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2)的体外抗病毒活性和优化剂量设计预测。
Clin Infect Dis. 2020 Jul 28;71(15):732-739. doi: 10.1093/cid/ciaa237.
6
Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China.意大利和中国新冠病毒(COVID-19/SARS-CoV-2)病死率的相似性
J Infect Dev Ctries. 2020 Feb 29;14(2):125-128. doi: 10.3855/jidc.12600.
7
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore.新加坡 2019 年新型冠状病毒肺炎患者的流行病学特征和临床病程
JAMA. 2020 Apr 21;323(15):1488-1494. doi: 10.1001/jama.2020.3204.
8
Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential.广谱抗病毒药物氯硝柳胺及其治疗潜力。
ACS Infect Dis. 2020 May 8;6(5):909-915. doi: 10.1021/acsinfecdis.0c00052. Epub 2020 Mar 10.
9
[Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China].中国北方六省(自治区)31例儿童2019新型冠状病毒感染的临床分析
Zhonghua Er Ke Za Zhi. 2020 Apr 2;58(4):269-274. doi: 10.3760/cma.j.cn112140-20200225-00138.
10
[Advances in the research of mechanism and related immunotherapy on the cytokine storm induced by coronavirus disease 2019].[新型冠状病毒肺炎细胞因子风暴的机制及相关免疫治疗研究进展]
Zhonghua Shao Shang Za Zhi. 2020 Jun 20;36(6):471-475. doi: 10.3760/cma.j.cn501120-20200224-00088.